A Study Evaluating the Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis
Clinical trial NCT03224351 · COMPLETED
Trial details
- NCT number
- NCT03224351
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2018-02-28
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.